Although the roles of cAMP – PKA/EPAC in lipid homoeostasis-related cardiovascular diseases are mostly in the basic research stage, these findings indicate that this signalling pathway has certain preventive and therapeutic value. The gene discussed is RAPGEF4; the disease is cardiovascular disorder.